Review





Similar Products

94
Miltenyi Biotec anti human cd69 fitc
Anti Human Cd69 Fitc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd69+fitc/CD69+Antibody%2C+anti-human/pmc13006415-64-0-3
Average 94 stars, based on 1 article reviews
anti human cd69 fitc - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

94
Miltenyi Biotec 130 095 212 custom anti human cd69 fitc miltenyi biotec
130 095 212 Custom Anti Human Cd69 Fitc Miltenyi Biotec, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd69+fitc/CD69+Antibody%2C+anti-human/pm41709452-498-238-242
Average 94 stars, based on 1 article reviews
130 095 212 custom anti human cd69 fitc miltenyi biotec - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

93
Miltenyi Biotec cd69 fitc
( A ) Flow cytometric analysis (FCA) of CD25 (left) and <t>CD69</t> (right) staining and quantification in CTL, n = 6/11 individual patients. ( B ) FCA of lymphocyte-activation gene 3 (LAG3), programmed cell death protein 1 (PD1), and T-cell immunoglobulin and mucin-domain containing-3 (TIM3) staining and quantification as indicated, n = 6/4 (not activated/+CD3/CD28) individual patients. P values (left to right): 0.2842, 0.2188, 0.6875, 0.5494, 0.1250, and >0.9999. ( C ) Quantification of relative cytotoxicity using a flow cytometric killing assay, n = 5 individual patients. ( D ) Quantification of caspase-3 activity reporter using a CTL-K562 killing assay, n = 4 individual patients. Data were represented as mean ± SEM with dots indicating individual values ( A , B ) or as individual data points ( C , D ). P values: as indicated, paired t -test or Wilcoxon matched-pairs signed-rank test, as appropriate.
Cd69 Fitc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd69+fitc/CD69+Antibody%2C+anti-human%2C+REAfinity/pmc12686421-8-0-3
Average 93 stars, based on 1 article reviews
cd69 fitc - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

94
Miltenyi Biotec anti cd69 fitc
( A ) Flow cytometric analysis (FCA) of CD25 (left) and <t>CD69</t> (right) staining and quantification in CTL, n = 6/11 individual patients. ( B ) FCA of lymphocyte-activation gene 3 (LAG3), programmed cell death protein 1 (PD1), and T-cell immunoglobulin and mucin-domain containing-3 (TIM3) staining and quantification as indicated, n = 6/4 (not activated/+CD3/CD28) individual patients. P values (left to right): 0.2842, 0.2188, 0.6875, 0.5494, 0.1250, and >0.9999. ( C ) Quantification of relative cytotoxicity using a flow cytometric killing assay, n = 5 individual patients. ( D ) Quantification of caspase-3 activity reporter using a CTL-K562 killing assay, n = 4 individual patients. Data were represented as mean ± SEM with dots indicating individual values ( A , B ) or as individual data points ( C , D ). P values: as indicated, paired t -test or Wilcoxon matched-pairs signed-rank test, as appropriate.
Anti Cd69 Fitc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd69+fitc/CD69+Antibody%2C+anti-human%2C+FITC/pmc12362413-318-18-20
Average 94 stars, based on 1 article reviews
anti cd69 fitc - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

94
Miltenyi Biotec cd69 antibody, anti-mouse, fitc, reafinity
( A ) Flow cytometric analysis (FCA) of CD25 (left) and <t>CD69</t> (right) staining and quantification in CTL, n = 6/11 individual patients. ( B ) FCA of lymphocyte-activation gene 3 (LAG3), programmed cell death protein 1 (PD1), and T-cell immunoglobulin and mucin-domain containing-3 (TIM3) staining and quantification as indicated, n = 6/4 (not activated/+CD3/CD28) individual patients. P values (left to right): 0.2842, 0.2188, 0.6875, 0.5494, 0.1250, and >0.9999. ( C ) Quantification of relative cytotoxicity using a flow cytometric killing assay, n = 5 individual patients. ( D ) Quantification of caspase-3 activity reporter using a CTL-K562 killing assay, n = 4 individual patients. Data were represented as mean ± SEM with dots indicating individual values ( A , B ) or as individual data points ( C , D ). P values: as indicated, paired t -test or Wilcoxon matched-pairs signed-rank test, as appropriate.
Cd69 Antibody, Anti Mouse, Fitc, Reafinity, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd69+fitc/CD69+Antibody%2C+anti-mouse%2C+FITC%2C+REAfinity/custom%40130-115-574%4040678524
Average 94 stars, based on 1 article reviews
cd69 antibody, anti-mouse, fitc, reafinity - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

94
Miltenyi Biotec anti mouse cd69 fitc
( A ) Flow cytometric analysis (FCA) of CD25 (left) and <t>CD69</t> (right) staining and quantification in CTL, n = 6/11 individual patients. ( B ) FCA of lymphocyte-activation gene 3 (LAG3), programmed cell death protein 1 (PD1), and T-cell immunoglobulin and mucin-domain containing-3 (TIM3) staining and quantification as indicated, n = 6/4 (not activated/+CD3/CD28) individual patients. P values (left to right): 0.2842, 0.2188, 0.6875, 0.5494, 0.1250, and >0.9999. ( C ) Quantification of relative cytotoxicity using a flow cytometric killing assay, n = 5 individual patients. ( D ) Quantification of caspase-3 activity reporter using a CTL-K562 killing assay, n = 4 individual patients. Data were represented as mean ± SEM with dots indicating individual values ( A , B ) or as individual data points ( C , D ). P values: as indicated, paired t -test or Wilcoxon matched-pairs signed-rank test, as appropriate.
Anti Mouse Cd69 Fitc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd69+fitc/CD69+Antibody%2C+anti-mouse%2C+REAfinity/pmc12268933-21-0-4
Average 94 stars, based on 1 article reviews
anti mouse cd69 fitc - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

90
Thermo Fisher fitc-conjugated anti-cd69 (h1.2f3)
( A ) Flow cytometric analysis (FCA) of CD25 (left) and <t>CD69</t> (right) staining and quantification in CTL, n = 6/11 individual patients. ( B ) FCA of lymphocyte-activation gene 3 (LAG3), programmed cell death protein 1 (PD1), and T-cell immunoglobulin and mucin-domain containing-3 (TIM3) staining and quantification as indicated, n = 6/4 (not activated/+CD3/CD28) individual patients. P values (left to right): 0.2842, 0.2188, 0.6875, 0.5494, 0.1250, and >0.9999. ( C ) Quantification of relative cytotoxicity using a flow cytometric killing assay, n = 5 individual patients. ( D ) Quantification of caspase-3 activity reporter using a CTL-K562 killing assay, n = 4 individual patients. Data were represented as mean ± SEM with dots indicating individual values ( A , B ) or as individual data points ( C , D ). P values: as indicated, paired t -test or Wilcoxon matched-pairs signed-rank test, as appropriate.
Fitc Conjugated Anti Cd69 (H1.2f3), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd69+fitc/anti+cd69/pm40381992-72-109-112
Average 90 stars, based on 1 article reviews
fitc-conjugated anti-cd69 (h1.2f3) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

93
Cell Signaling Technology Inc cd69 h1 2f3 hamster mab hamster mab fitc conjugate
( A ) Flow cytometric analysis (FCA) of CD25 (left) and <t>CD69</t> (right) staining and quantification in CTL, n = 6/11 individual patients. ( B ) FCA of lymphocyte-activation gene 3 (LAG3), programmed cell death protein 1 (PD1), and T-cell immunoglobulin and mucin-domain containing-3 (TIM3) staining and quantification as indicated, n = 6/4 (not activated/+CD3/CD28) individual patients. P values (left to right): 0.2842, 0.2188, 0.6875, 0.5494, 0.1250, and >0.9999. ( C ) Quantification of relative cytotoxicity using a flow cytometric killing assay, n = 5 individual patients. ( D ) Quantification of caspase-3 activity reporter using a CTL-K562 killing assay, n = 4 individual patients. Data were represented as mean ± SEM with dots indicating individual values ( A , B ) or as individual data points ( C , D ). P values: as indicated, paired t -test or Wilcoxon matched-pairs signed-rank test, as appropriate.
Cd69 H1 2f3 Hamster Mab Hamster Mab Fitc Conjugate, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd69+fitc/CD69+Hamster+mAb/pm40015339-93-2-8
Average 93 stars, based on 1 article reviews
cd69 h1 2f3 hamster mab hamster mab fitc conjugate - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

94
Miltenyi Biotec fitc cd69
( A ) Flow cytometric analysis (FCA) of CD25 (left) and <t>CD69</t> (right) staining and quantification in CTL, n = 6/11 individual patients. ( B ) FCA of lymphocyte-activation gene 3 (LAG3), programmed cell death protein 1 (PD1), and T-cell immunoglobulin and mucin-domain containing-3 (TIM3) staining and quantification as indicated, n = 6/4 (not activated/+CD3/CD28) individual patients. P values (left to right): 0.2842, 0.2188, 0.6875, 0.5494, 0.1250, and >0.9999. ( C ) Quantification of relative cytotoxicity using a flow cytometric killing assay, n = 5 individual patients. ( D ) Quantification of caspase-3 activity reporter using a CTL-K562 killing assay, n = 4 individual patients. Data were represented as mean ± SEM with dots indicating individual values ( A , B ) or as individual data points ( C , D ). P values: as indicated, paired t -test or Wilcoxon matched-pairs signed-rank test, as appropriate.
Fitc Cd69, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd69+fitc/CD69+Antibody%2C+anti-mouse%2C+REAfinity/pm39889383-157-57-59
Average 94 stars, based on 1 article reviews
fitc cd69 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

Image Search Results


( A ) Flow cytometric analysis (FCA) of CD25 (left) and CD69 (right) staining and quantification in CTL, n = 6/11 individual patients. ( B ) FCA of lymphocyte-activation gene 3 (LAG3), programmed cell death protein 1 (PD1), and T-cell immunoglobulin and mucin-domain containing-3 (TIM3) staining and quantification as indicated, n = 6/4 (not activated/+CD3/CD28) individual patients. P values (left to right): 0.2842, 0.2188, 0.6875, 0.5494, 0.1250, and >0.9999. ( C ) Quantification of relative cytotoxicity using a flow cytometric killing assay, n = 5 individual patients. ( D ) Quantification of caspase-3 activity reporter using a CTL-K562 killing assay, n = 4 individual patients. Data were represented as mean ± SEM with dots indicating individual values ( A , B ) or as individual data points ( C , D ). P values: as indicated, paired t -test or Wilcoxon matched-pairs signed-rank test, as appropriate.

Journal: EMBO Molecular Medicine

Article Title: Mitochondrial damage drives T-cell immunometabolic paralysis after major surgery

doi: 10.1038/s44321-025-00324-1

Figure Lengend Snippet: ( A ) Flow cytometric analysis (FCA) of CD25 (left) and CD69 (right) staining and quantification in CTL, n = 6/11 individual patients. ( B ) FCA of lymphocyte-activation gene 3 (LAG3), programmed cell death protein 1 (PD1), and T-cell immunoglobulin and mucin-domain containing-3 (TIM3) staining and quantification as indicated, n = 6/4 (not activated/+CD3/CD28) individual patients. P values (left to right): 0.2842, 0.2188, 0.6875, 0.5494, 0.1250, and >0.9999. ( C ) Quantification of relative cytotoxicity using a flow cytometric killing assay, n = 5 individual patients. ( D ) Quantification of caspase-3 activity reporter using a CTL-K562 killing assay, n = 4 individual patients. Data were represented as mean ± SEM with dots indicating individual values ( A , B ) or as individual data points ( C , D ). P values: as indicated, paired t -test or Wilcoxon matched-pairs signed-rank test, as appropriate.

Article Snippet: CD69 FITC , Miltenyi , 130-112-801.

Techniques: Staining, Activation Assay, Activity Assay

( A ) FCA of MitoTracker green and quantification in isolated mitochondria from CTL, n = 7 individual patients. ( B ) FCA of JC1 green and quantification of red/green fluorescence in isolated mitochondria from CTL, n = 4 individual patients. ( C ) Immunoblot of OXPHOS complexes using isolated mitochondria of CTL and normalized densitometric quantification of complex V, n = 5 individual patients. I–V complex I–V; H heat shock protein 60 (HSP60). Subunits detected by the antibody cocktail: complex I: subunit NDUFB8; complex II: subunit 30 kDa (SDHB); complex III: subunit Core 2 (UQCRC2); complex IV: subunit II (COXII); complex V: ATP synthase subunit alpha (ATP5). ( D , E ) Representative immunoblot of mitochondrial fusion and fission proteins of isolated mitochondria of CTL ( D ) and normalized densitometric quantification ( E ) of the respective proteins, n = 5/4/3 individual patients. ( F ) Representative projections of 3D image stacks of CTL stained with MitoTracker (MT, green, left) and the respective skeleton images (white, right), generated using mitochondrial analyzer, time points as indicated, representative of six individual patients. ( G ) Quantification of mitochondrial count per cell, n = 29 cells from three individual patients. ( H ) Quantification of mitochondrial length (left) and mean mitochondrial area using mitochondrial analyzer (right), n = 180/170 mitochondria from 14/22 cells from three individual patients (length) and n = 50 cells from three individual patients (area). ( I ) Representative projection of 3D image stacks (two per time point) of translocated mitochondria to the IS in CTL as indicated by MitoTracker (MT) Deep Red and CD3 FITC staining, and quantification of mitochondrial translocation to the CTL IS, time points as indicated, n = 14 from 5 individual patients. If not stated otherwise, data were represented as mean ± SEM. P values as indicated, paired t -test or Wilcoxon matched-pairs signed-rank test ( A – E ), and unpaired t -test or Mann–Whitney test ( G – I ), as appropriate. .

Journal: EMBO Molecular Medicine

Article Title: Mitochondrial damage drives T-cell immunometabolic paralysis after major surgery

doi: 10.1038/s44321-025-00324-1

Figure Lengend Snippet: ( A ) FCA of MitoTracker green and quantification in isolated mitochondria from CTL, n = 7 individual patients. ( B ) FCA of JC1 green and quantification of red/green fluorescence in isolated mitochondria from CTL, n = 4 individual patients. ( C ) Immunoblot of OXPHOS complexes using isolated mitochondria of CTL and normalized densitometric quantification of complex V, n = 5 individual patients. I–V complex I–V; H heat shock protein 60 (HSP60). Subunits detected by the antibody cocktail: complex I: subunit NDUFB8; complex II: subunit 30 kDa (SDHB); complex III: subunit Core 2 (UQCRC2); complex IV: subunit II (COXII); complex V: ATP synthase subunit alpha (ATP5). ( D , E ) Representative immunoblot of mitochondrial fusion and fission proteins of isolated mitochondria of CTL ( D ) and normalized densitometric quantification ( E ) of the respective proteins, n = 5/4/3 individual patients. ( F ) Representative projections of 3D image stacks of CTL stained with MitoTracker (MT, green, left) and the respective skeleton images (white, right), generated using mitochondrial analyzer, time points as indicated, representative of six individual patients. ( G ) Quantification of mitochondrial count per cell, n = 29 cells from three individual patients. ( H ) Quantification of mitochondrial length (left) and mean mitochondrial area using mitochondrial analyzer (right), n = 180/170 mitochondria from 14/22 cells from three individual patients (length) and n = 50 cells from three individual patients (area). ( I ) Representative projection of 3D image stacks (two per time point) of translocated mitochondria to the IS in CTL as indicated by MitoTracker (MT) Deep Red and CD3 FITC staining, and quantification of mitochondrial translocation to the CTL IS, time points as indicated, n = 14 from 5 individual patients. If not stated otherwise, data were represented as mean ± SEM. P values as indicated, paired t -test or Wilcoxon matched-pairs signed-rank test ( A – E ), and unpaired t -test or Mann–Whitney test ( G – I ), as appropriate. .

Article Snippet: CD69 FITC , Miltenyi , 130-112-801.

Techniques: Isolation, Fluorescence, Western Blot, Staining, Generated, Translocation Assay, MANN-WHITNEY

( A ) FCA of MitoTracker green and quantification in CD8 + CTL, n = 7 individual patients. ( B ) Representative Seahorse OCR plot. ( C ) Fold change of basal OCR, maximum OCR, spare respiratory capacity (SRC) and ATP production, n = 6 individual patients. ( D ) Quantification of mitochondrial length, n = 92 mitochondria from 28 cells from three individual patients. ( E ) Quantification of mitochondrial count per cell, n = 30/26 cells from three individual patients. ( F ) Representative confocal microscopy image of mitochondria translocated to the TCR in CTL as indicated by MitoTracker (MT) Deep Red and CD3 FITC staining, T2 image as depicted in Fig. , upper right image. ( G ) Quantification of mitochondrial translocation in proximity to the CTL IS, n = 12 from four individual patients. ( H ) Representative impedance plot and ( I ) quantification of relative CTL cytotoxicity using ECIS, n = 6 individual patients. If not stated otherwise, data are represented as mean ± SEM. P values as indicated, one-sample t -test ( C ), paired t -test or Wilcoxon matched-pairs signed-rank test ( A – C, H , I ), and unpaired t -test or Mann–Whitney test ( D – G ), as appropriate. .

Journal: EMBO Molecular Medicine

Article Title: Mitochondrial damage drives T-cell immunometabolic paralysis after major surgery

doi: 10.1038/s44321-025-00324-1

Figure Lengend Snippet: ( A ) FCA of MitoTracker green and quantification in CD8 + CTL, n = 7 individual patients. ( B ) Representative Seahorse OCR plot. ( C ) Fold change of basal OCR, maximum OCR, spare respiratory capacity (SRC) and ATP production, n = 6 individual patients. ( D ) Quantification of mitochondrial length, n = 92 mitochondria from 28 cells from three individual patients. ( E ) Quantification of mitochondrial count per cell, n = 30/26 cells from three individual patients. ( F ) Representative confocal microscopy image of mitochondria translocated to the TCR in CTL as indicated by MitoTracker (MT) Deep Red and CD3 FITC staining, T2 image as depicted in Fig. , upper right image. ( G ) Quantification of mitochondrial translocation in proximity to the CTL IS, n = 12 from four individual patients. ( H ) Representative impedance plot and ( I ) quantification of relative CTL cytotoxicity using ECIS, n = 6 individual patients. If not stated otherwise, data are represented as mean ± SEM. P values as indicated, one-sample t -test ( C ), paired t -test or Wilcoxon matched-pairs signed-rank test ( A – C, H , I ), and unpaired t -test or Mann–Whitney test ( D – G ), as appropriate. .

Article Snippet: CD69 FITC , Miltenyi , 130-112-801.

Techniques: Confocal Microscopy, Staining, Translocation Assay, MANN-WHITNEY